Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 1
2007 1
2010 1
2011 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).
Kosmidis PA, Fountzilas G, Eleftheraki AG, Kalofonos HP, Pentheroudakis G, Skarlos D, Dimopoulos MA, Bafaloukos D, Pectasides D, Samantas E, Boukovinas J, Lambaki S, Katirtzoglou N, Bakogiannis C, Syrigos KN. Kosmidis PA, et al. Among authors: boukovinas j. Ann Oncol. 2011 Apr;22(4):827-834. doi: 10.1093/annonc/mdq445. Epub 2010 Sep 29. Ann Oncol. 2011. PMID: 20880999 Free article. Clinical Trial.
A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer.
Agelaki S, Syrigos K, Christophylakis C, Boukovinas J, Varthalitis J, Pavlakou G, Athanasiadis A, Kouroussis C, Vardakis N, Maltezakis G, Milaki G, Georgoulias V; Lung Cancer Subgroup, Hellenic Oncology Research Group. Agelaki S, et al. Among authors: boukovinas j. Oncology. 2004;66(3):192-6. doi: 10.1159/000077994. Oncology. 2004. PMID: 15218309 Clinical Trial.
Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.
Kosmidis P, Mylonakis N, Nicolaides C, Kalophonos C, Samantas E, Boukovinas J, Fountzilas G, Skarlos D, Economopoulos T, Tsavdaridis D, Papakostas P, Bacoyiannis C, Dimopoulos M. Kosmidis P, et al. Among authors: boukovinas j. J Clin Oncol. 2002 Sep 1;20(17):3578-85. doi: 10.1200/JCO.2002.12.112. J Clin Oncol. 2002. PMID: 12202657 Clinical Trial.
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
Kosmidis P, Fountzilas G, Baka S, Samantas E, Dimopoulos AM, Gogas H, Skarlos D, Papacostas P, Boukovinas J, Bakogiannis Ch, Pantelakos P, Athanasiou H, Misailidou D, Tsekeris P, Pavlidis N. Kosmidis P, et al. Among authors: boukovinas j. Anticancer Res. 2007 Nov-Dec;27(6C):4391-5. Anticancer Res. 2007. PMID: 18214050 Free article. Clinical Trial.
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
Stathopoulos GP, Syrigos K, Aravantinos G, Polyzos A, Papakotoulas P, Fountzilas G, Potamianou A, Ziras N, Boukovinas J, Varthalitis J, Androulakis N, Kotsakis A, Samonis G, Georgoulias V. Stathopoulos GP, et al. Among authors: boukovinas j. Br J Cancer. 2006 Sep 4;95(5):587-92. doi: 10.1038/sj.bjc.6603301. Epub 2006 Aug 8. Br J Cancer. 2006. PMID: 16909140 Free PMC article. Clinical Trial.
Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group.
Ignatiadis M, Mavroudis D, Veslemes M, Boukovinas J, Syrigos K, Agelidou M, Agelidou A, Gerogianni A, Pavlakou G, Tselepatiotis E, Nikolakopoulos J, Georgoulias V. Ignatiadis M, et al. Among authors: boukovinas j. Clin Lung Cancer. 2005 Nov;7(3):183-9. doi: 10.3816/CLC.2005.n.034. Clin Lung Cancer. 2005. PMID: 16354313 Clinical Trial.